Recombinant Human Protein ATP1B4 (ATP1B4)

What is ATP1B4 and how has its function evolved across vertebrate species?

The protein's structural evolution includes the acquisition of an extended glutamate-rich N-terminal domain in placental mammals, which contributes to its nuclear localization and regulatory functions . These modifications allowed ATP1B4 to transition from membrane ion transport to transcriptional regulation, particularly in developing muscle tissue.

What are the key structural characteristics of human ATP1B4?

Human ATP1B4 is a 357 amino acid protein with the following key structural features:

A distinguishing structural feature of mammalian ATP1B4 is its extended glutamate-rich N-terminal domain, which is critical for its nuclear localization and interaction with transcriptional coregulators . The protein retains a single transmembrane domain despite its functional transition from membrane to nuclear protein, suggesting structural conservation despite functional divergence.

What expression patterns does ATP1B4 display during development?

ATP1B4 shows distinct temporal and tissue-specific expression patterns that provide insights into its biological function. The highest expression levels are observed during late fetal and early postnatal development, particularly in myocytes . This temporal expression profile suggests that ATP1B4 plays a critical role in perinatal muscle development.

In placental mammals, ATP1B4 expression is largely restricted to skeletal and cardiac muscle tissues, where it localizes to the inner nuclear membrane . The protein's expression gradually decreases in mature muscle tissue, indicating its primary function may be in developmental processes rather than maintenance of adult muscle physiology.

Research methodologies for studying developmental expression patterns include:

• Quantitative PCR for temporal expression profiling

• Immunohistochemistry for tissue localization

• Reporter gene constructs to track expression in model organisms

• Single-cell RNA sequencing to identify cell-specific expression

How does ATP1B4 function as a transcriptional coregulator?

In placental mammals, ATP1B4 has evolved to function as a transcriptional coregulator, particularly during muscle development. Research indicates that it interacts with SNW1 (SNW domain-containing protein 1), a nuclear transcriptional coregulator involved in the regulation of transforming growth factor beta (TGF-beta) signaling pathways .

The methodological approach to studying this function involves:

• Co-immunoprecipitation assays to confirm protein-protein interactions

• Chromatin immunoprecipitation (ChIP) to identify genomic binding regions

• Reporter gene assays to quantify transcriptional effects

• Proximity ligation assays to visualize protein interactions in situ

ATP1B4 appears to participate in the regulation of gene expression programs essential for proper muscle development and maturation. This function represents a complete departure from its ancestral role in ion transport, demonstrating how evolutionary processes can repurpose existing proteins for entirely new cellular functions.

What are the metabolic consequences of ATP1B4 ablation in animal models?

Recent research using ATP1B4 knockout mice has revealed surprising metabolic phenotypes. Beta-M deficient (Atp1b4-/Y) mice exhibit:

• Significantly lower body weight

• Remarkably low adiposity

• Lower fasting blood glucose levels

• Enhanced insulin sensitivity

• Improved glucose tolerance

• Higher heat production

• Increased food intake

• Elevated oxygen consumption (especially during dark periods)

• Higher locomotor activity

• Lower respiratory exchange ratio (indicating preferential fat metabolism)

These findings suggest that ATP1B4 plays a previously unrecognized role in regulating metabolism in adult mice. The ablation of ATP1B4 appears to protect against obesity and enhance metabolic function, potentially through alterations in energy expenditure and substrate utilization .

Researchers investigating these metabolic effects should consider the following methodological approaches:

• Comprehensive metabolic phenotyping

• Glucose and insulin tolerance testing

• Indirect calorimetry for energy expenditure

• Molecular analysis of metabolic tissues

• Transcriptomic and proteomic profiling

How can evolutionary insights into ATP1B4 function inform research approaches?

The evolutionary repurposing of ATP1B4 from an ion transport protein to a nuclear transcriptional regulator represents a unique opportunity to study evolutionary co-option in mammals. According to recent research, ablation of Atp1b4 essentially simulates a scenario where a specific stage in mammalian evolution is bypassed . This provides a valuable model for understanding how evolutionary changes in protein function contribute to species-specific phenotypes.

Research methodologies leveraging this evolutionary perspective include:

• Comparative genomics across vertebrate species

• Functional analysis of ATP1B4 orthologs from different species

• Generation of chimeric proteins combining domains from different species

• Rescue experiments in knockout models using orthologs from different species

Interestingly, the metabolic phenotype observed in Atp1b4 knockout mice suggests that bypassing the co-option of ATP1B4 potentially reduces susceptibility to obesity . This finding provides a novel perspective on how evolutionary adaptations may influence disease susceptibility in modern environments.

What expression systems are optimal for producing recombinant ATP1B4 protein?

Several expression systems have been successfully employed for producing recombinant ATP1B4 protein, each with distinct advantages depending on the research application:

For studies investigating ATP1B4's nuclear functions and interactions with transcriptional machinery, mammalian expression systems are generally preferred as they provide the proper cellular environment for post-translational modifications and protein folding . Researchers should select the expression system based on the specific requirements of their experimental design, considering factors such as protein yield, post-translational modifications, and functional integrity.

What techniques are most effective for studying ATP1B4's subcellular localization?

The dramatic shift in ATP1B4's subcellular localization from the plasma membrane in lower vertebrates to the inner nuclear membrane in placental mammals represents a key aspect of its functional evolution. Studying this localization requires specialized techniques:

• Immunofluorescence microscopy with co-localization markers for:

  • Nuclear envelope (lamin proteins)

  • Inner nuclear membrane (emerin, LAP2)

  • Plasma membrane (Na+/K+-ATPase α-subunit)

• Subcellular fractionation with Western blotting

  • Nuclear, cytoplasmic, and membrane fractions

  • Differential detergent extraction for membrane subdomains

• Electron microscopy with immunogold labeling

  • Ultra-structural localization in different cell types

  • Species-specific differences in localization

• Live-cell imaging with fluorescently tagged proteins

  • Dynamics of localization during development

  • Response to cellular stressors or stimuli

These methodological approaches can be combined to provide complementary data on ATP1B4's subcellular distribution and how it relates to function in different species and developmental stages.

How can researchers effectively study the involvement of ATP1B4 in the integrated stress response?

Recent research has identified connections between mitochondrial function, stress responses, and nuclear gene regulation that may involve ATP1B4. The integrated stress response (ISR) involves activating transcription factor 4 (ATF4) as a key regulator of cellular stress adaptation . Given ATP1B4's nuclear localization and role in transcriptional regulation, investigating potential connections to the ISR represents an important research direction.

Methodological approaches include:

• Gene expression analysis following cellular stressors

  • Quantitative PCR for stress response genes

  • RNA sequencing for global transcriptional changes

  • ChIP-seq for identifying binding sites

• Protein interaction studies

  • Co-immunoprecipitation with ATF4 and other stress response factors

  • Proximity ligation assays in stressed and unstressed cells

  • Yeast two-hybrid screening for novel interaction partners

• Functional assays

  • Reporter gene assays for ISR-responsive elements

  • CRISPR-mediated gene editing to assess functional requirements

  • Metabolic analyses under stress conditions

Understanding ATP1B4's potential role in stress responses could provide valuable insights into its evolved functions in placental mammals and potential connections to metabolic regulation.

What is the evidence linking ATP1B4 to human disease?

ATP1B4 has been implicated in several pathological conditions, although the mechanisms remain incompletely understood. Current evidence suggests associations with:

• Congenital anomalies of kidney and urinary tract 2

  • Potential developmental roles in kidney formation

  • Altered gene regulation during organogenesis

• Thyrotoxic periodic paralysis

  • Possible involvement in muscle excitability

  • Connections to ion homeostasis despite functional transition

• Metabolic disorders

  • Knockout studies indicate protection against obesity

  • Enhanced glucose homeostasis in ATP1B4-deficient mice

Research methodologies for investigating these disease connections include:

• Genetic association studies in patient populations

• Functional characterization of disease-associated variants

• Animal models of ATP1B4 dysfunction

• Tissue-specific conditional knockout approaches

How might ATP1B4 represent a therapeutic target for metabolic disorders?

The striking metabolic phenotype observed in ATP1B4 knockout mice suggests potential therapeutic applications for targeting this protein in metabolic disorders. Mice lacking ATP1B4 show protection against obesity, enhanced insulin sensitivity, and improved glucose tolerance , indicating that inhibition of ATP1B4 function might provide metabolic benefits.

Methodological approaches for therapeutic development include:

• High-throughput screening for small molecule inhibitors

  • Disruptors of protein-protein interactions

  • Modulators of nuclear localization

  • Regulators of expression or stability

• Antisense oligonucleotides or siRNA approaches

  • Tissue-specific delivery systems

  • Temporal control of inhibition

  • Dose-response characterization

• Structure-based drug design

  • Targeting specific functional domains

  • Rational design based on interaction interfaces

• Validation in disease models

  • Diet-induced obesity

  • Genetic models of insulin resistance

  • Pharmacokinetic/pharmacodynamic relationships

The evolutionary co-option of ATP1B4 in placental mammals presents an intriguing target, as inhibiting its acquired functions might restore metabolic characteristics that existed prior to this evolutionary change . This approach represents a novel perspective in metabolic disease therapy, essentially "reversing" a specific evolutionary adaptation that may contribute to susceptibility to modern metabolic diseases.

What are the key unanswered questions regarding ATP1B4 function?

Despite significant advances in understanding ATP1B4, several important questions remain:

• What is the complete set of transcriptional targets regulated by ATP1B4?

  • Genome-wide binding profiles

  • Cell-type specific regulatory networks

  • Temporal dynamics during development

• How does ATP1B4 interact with the broader transcriptional machinery?

  • Composition of regulatory complexes

  • Chromatin remodeling activities

  • Epigenetic modifications

• What signals regulate ATP1B4 expression and activity?

  • Developmental cues

  • Metabolic signals

  • Stress responses

• How do post-translational modifications affect ATP1B4 function?

  • Phosphorylation states

  • Ubiquitination and stability

  • Other modifications

• What are the molecular mechanisms underlying ATP1B4's effects on metabolism?

  • Direct transcriptional targets

  • Tissue-specific roles

  • Systemic metabolic integration

What technologies are emerging as valuable for ATP1B4 research?

Several cutting-edge technologies are particularly promising for advancing ATP1B4 research:

• CRISPR-based approaches

  • Precise genome editing for functional studies

  • CRISPRi/CRISPRa for modulating expression

  • Base editing for studying specific variants

• Single-cell technologies

  • scRNA-seq for expression profiling in heterogeneous tissues

  • Spatial transcriptomics for tissue context

  • Single-cell proteomics for protein-level analysis

• Cryo-electron microscopy

  • Structural determination of ATP1B4 complexes

  • Visualization of interaction interfaces

  • Conformational dynamics

• Proteomics approaches

  • Interaction proteomics for comprehensive binding partners

  • Post-translational modification mapping

  • Protein turnover and dynamics

• Metabolomics

  • Comprehensive metabolic profiling in knockout models

  • Flux analysis for metabolic pathways

  • Integration with transcriptomics data

These technologies, particularly when applied in combination, promise to provide deeper insights into ATP1B4's evolved functions and potential therapeutic applications.